Immunological development and cardiovascular function are normal in annexin VI null mutant mice

Molecular and Cellular Biology

Volumn 19, Issue 12, 1999, Pages 8028-8032

  Hawkins, Tim E ^a   Roes, Jürgen ^a   Rees, Daryl ^b   Monkhouse, Jayne ^b   Moss, Stephen E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALPHOBINDIN II;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; HETEROZYGOSITY; IMMUNE SYSTEM; MELANOCYTE; MOUSE; MOUSE MUTANT; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEXUAL MATURITY;

ANIMALIA;

EID: 0033512782     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.12.8028     Document Type: Article

References (26)

1. Benz, J., and A. Hofmann. 1997. Annexins: from structure to function. Biol. Chem. Hoppe-Seyler 378:177-183.
2. Benz, J., A. Bergner, A. Hofmann, P. Demange, P. Göttig, S. Liemann, R. Huber, and D. Voges. 1996. The structure of recombinant human annexin VI in crystals and membrane-bound. J. Mol. Biol. 260:638-643.
3. Clark, D. M., S. E. Moss, N. A. Wright, and M. J. Crumpton. 1991. Expression of annexin VI (p68, 67 kDa-calelectrin) in normal human tissues: evidence for developmental regulation in B-and T-lymphocytes. Histochemistry 96:405-412.
4. 2+ release channel activity from sarcoplasmic reticulum by annexin VI (67-kDa calcimedin). J. Biol. Chem. 265:15894-15899.
5. Doubell, A. F., C. Lazure, C. Charbonneau, and G. Thibault. 1993. Identification and immunolocalisation of annexins V and VI, the major cardiac annexins, in rat heart. Cardiovasc. Res. 27:1359-1367.
6. Francia, G., S. D. Mitchell, S. E. Moss, A. M. Hanby, J. F. Marshall, and I. R. Hart. 1996. Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res. 56:3855-3858.
7. Gerke, V., and S. E. Moss. 1997. Annexins and membrane dynamics. Biochim. Biophys. Acta 1357:129-154.
8. Gunteski-Hamblin, A. M., G. J. Song, R. A. Walsh, M. Frenzke, G. P. Boivin, G. W. Dorn II, M. A. Kaetzel, N. D. Horseman, and J. R. Dedman. 1996. Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am. J. Physiol. 270:H1091-H1100.
9. Hawkins, T. E., and S. E. Moss. Unpublished data.
10. Hazarika, P., A. Sheldon, M. A. Kaetzel, M. Díaz-Muñoz, S. L. Hamilton, and J. R. Dedman. 1991. Regulation of the sarcoplasmic reticulum Ca(2+)-release channel requires intact annexin VI. J. Cell. Biochem. 46:86-93.
11. Huber, R., J. Romisch, and E. P. Paques. 1990. The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes. EMBO J. 9:3867-3874.
12. Jäckle, S., V. Beisiegel, F. Rinninger, F. Buck, A. Grigoleit, A. Block, I. Gröger, H. Greten, and E. Windler. 1994. Annexin VI, a marker protein of hepatocytic endosomes. J. Biol. Chem. 269:1026-1032.
13. Kamal, A., Y.-S. Ying, and R. G. W. Anderson. 1998. Annexin VI-mediated loss of spectrin during coated pit budding is coupled to delivery of LDL to lysosomes. J. Cell Biol. 142:937-947.
14. 2+ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative. Biochim. Biophys. Acta 1330:1-7.
15. Kaneko, N., H. Ago, R. Matsuda, E. Inagaki, and M. Miyano. 1997. Crystal structure of annexin V with its ligand K-201 as a calcium channel activity inhibitor. J. Mol. Biol. 274:16-20.
16. Lin, H. C., T. C. Südhof, and R. G. W. Anderson. 1991 Annexin VI is required for budding of clathrin-coated pits. Cell 70:283-291.
17. Ortega, D., A. Pol, M. Biermer, S. Jäckle, and C. Enrich. 1998. Annexin VI defines an apical endocytic compartment in rat liver hepatocytes. J. Cell Sci. 111:261-269.
18. Rahman, M. M., H. Iida, and Y. Shibata. 1997. Expression and localization of annexin V and annexin VI during limb bud formation in the rat fetus. Anat. Embryol. 195:31-39.
19. Rees, D. D., J. E. Monkhouse, D. Cambridge, and S. Moncada. 1998. Nitric oxide and the haemodynamic profile of endotoxin shock in the conscious mouse. Br. J. Pharmacol. 124:540-546.
20. Roes, J., and K. Rajewsky. 1993. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J. Exp. Med. 177:45-55.
21. Schnitzer, J. E., J. Liu, and P. Oh. 1995. Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J. Biol. Chem. 270: 14399-14404.
22. Smith, P. D., A. Davies, M. J. Crumpton, and S. E. Moss. 1994. Structure of the human annexin VI gene. Proc. Natl Acad. Sci. USA 91:2713-2717.
23. Smith, P. D., and S. E. Moss. 1994. Structural evolution of the annexin supergene family. Trends Genet. 10:241-246.
24. Smythe, E., P. D. Smith, S. M. Jacob, J. Theobald, and S. E. Moss. 1994. Endocytosis occurs independently of annexin VI in human A431 cells. J. Cell Biol. 124:301-306.
25. Theobald, J., P. D. Smith, S. M. Jacob, and S. E. Moss. 1994. Expression of annexin VI in A431 carcinoma cells suppresses proliferation: a possible role for annexin VI in cell growth regulation. Biochim. Biophys. Acta 1223:383-390.
26. Theobald, J., A. Hanby, K. Patel, and S. E. Moss. 1995. Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells. Br. J. Cancer 71:786-788.